Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Background. Multiple sclerosis (MS) is an autoimmune inflammatory disease of central nervous system (CNS). MS affects quality of Life (QOL) due to physical disability and other associated problems. Disease-modifying agents like interferon beta (IFNB) have been widely utilized in this patient populat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Abolfazli, R., Hosseini, A., Gholami, Kh., Javadi, M. R., Torkamandi, H., Emami, S.
Médium: Artigo
Jazyk:Inglês
Vydáno: International Scholarly Research Network 2012
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3423918/
https://ncbi.nlm.nih.gov/pubmed/22928117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/786526
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky